HWHaiyang Wang

Haiyang Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haiyang Wang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endovenous treatment via profunda femoral vein approach for iliofemoral venous obstruction with inadequate femoral vein inflow

    by Bo Wu, Haoyuan Wang, Yujia Li, Fuwen Chen, Jianming Sun, Haiyang Wang, Youhong Liu

    Introduction: This study aimed to evaluate the clinical efficacy of endovenous treatment (ET) via the profunda femoral vein (PFV) approach for iliofemoral venous obstruction with inadequate femoral vein (FV) inflow in patients with severe postthrombotic syndrome (PTS). Methods: A retrospective analysis included 32 patients who underwent this procedure between January 2021 and January 2023. Clinical symptoms were evaluated using the Villalta score and Venous Clinical Severity Score (VCSS) at baseline, 1 year, and 2 years. Patency rates were determined by duplex ultrasonography. Univariate logistic regression analysis was used to identify risk factors for in-stent restenosis (ISR). Results: The mean age of the patients was 65.5 ± 8.9 years, and 56.3% were men. Among 32 patients, technical success was achieved in all cases (100%). Postoperative in-stent thrombosis occurred in 18.8% (6/32) of patients. Kaplan–Meier analysis revealed primary patency rates of 100% ± 0%, 96.9% ± 3.1%, 93.8% ± 4.2%, 87.5% ± 5.9%, and 65.6% ± 8.4% at 1, 3, 6, 12, and 24 months, respectively. ISR developed in 11 patients, all of whom underwent reintervention, yielding a secondary patency rate of 87.5% ± 5.9% at 2 years. Baseline Villalta scores (17.4 ± 5.5) and VCSS (13.2 ± 2.5) significantly decreased to 6.5 ± 3.0 and 5.1 ± 1.8 at 2 years postoperatively (both p < 0.05). Anticoagulation noncompliance and history of iliofemoral deep vein thrombosis (DVT) were independent predictors of ISR. Conclusion: ET via the PFV approach is a safe and effective option for iliofemoral venous obstruction with inadequate FV inflow in severe PTS, providing favorable patency rates and significant symptom relief. Anticoagulation noncompliance and history of iliofemoral DVT are key factors for ISR.

  • Laparotomy combined with mechanical thrombectomy for acute, critical, noncirrhotic portal and mesenteric vein thrombosis

    by Haoyuan Wang, Bo Wu, Xiaotong Qi, Yuhang Zhou, Haiyang Wang, Bo Tang

    Introduction: The study aimed to evaluate the efficacy and safety of laparotomy combined with mechanical thrombectomy in patients with acute, critical, noncirrhotic porto-mesenteric vein thrombosis (NC-PMVT). Methods: Between January 2018 and January 2025, 20 patients diagnosed with acute, critical NC-PMVT, who underwent laparotomy with mechanical thrombectomy, were included in this study. Baseline characteristics, clinical presentation, and perioperative data were collected. Safety and efficacy were evaluated based on symptom relief, recanalization rate, technical success, and procedure-related complications. Recurrence and long-term complications were assessed over a 12-month follow-up. Results: The technical success rate was 100%. Intestinal resection was performed in eight patients, with a mean resected bowel length of 61.75 ± 9.75 cm. Abdominal pain was alleviated in 60% of patients by postoperative day 5. The mean length of hospital stay was 10 ± 3.91 days. At discharge, 12 (60%) patients achieved complete recanalization (CR) and eight (40%) demonstrated partial recanalization (PR). At follow-up, CR was observed in 16 (80%) patients, PR persisted in three (15%), and one died from an unrelated condition. All surviving patients achieved complete symptom resolution. No procedure-related complications or recurrences were reported during follow-up. Conclusion: Laparotomy with mechanical thrombectomy is demonstrated to be a safe and effective treatment for acute, critical NC-PMVT.


  • Incidence, risk factors, and clinical characteristics of deep vein thrombosis following combined radiofrequency ablation and sclerotherapy for varicose veins

    by Bo Wu, Haoyuan Wang, Yujia Li, Jianming Sun, Haiyang Wang, Haiyan Yan

    Objective: This study aims to investigate the incidence, risk factors, and clinical characteristics of deep vein thrombosis (DVT) following radiofrequency ablation (RFA) combined with sclerotherapy for varicose veins. Methods: A retrospective analysis was conducted on patients who underwent combined RFA and sclerotherapy between June 2018 and June 2024. The incidence of postoperative DVT and its clinical characteristics were evaluated, with 13 potential risk factors assessed through univariate and multivariate logistic regression. Patients with distal DVT were divided into two groups: Group A (treatment with prophylactic-dose anticoagulation) and Group B (no anticoagulation), with thrombus resolution outcomes compared between the groups. Results: Among 567 patients with varicose veins, including 226 males and 341 females (male-to-female ratio 1:1.51), with a mean age of 57.79 ± 11.38 years (range: 28–77 years), postoperative DVT occurred in 46 patients (8.11%), 36 of whom (78.26%) were diagnosed within 3 days. Thrombosis predominantly affected the muscular veins and posterior tibial veins (91.30%). Multivariate analysis identified a history of thrombosis, injection volume >10 mL of foam, and injection sites distal to the ankle joint as independent risk factors for DVT. Furthermore, Group A demonstrated a significantly lower prevalence of thrombosis at each time point compared to Group B ( p < .05). Conclusion: The incidence of postoperative DVT following combined RFA and foam sclerotherapy for varicose veins is relatively high, with the majority occurring in the early postoperative period. Thrombosis primarily affects the muscular and posterior tibial veins. A history of thrombosis, injection volume >10 mL of foam, and injection sites distal to the ankle joint are independent risk factors. Prophylactic-dose anticoagulation therapy may facilitate thrombus resolution in patients with distal DVT.


  • Age-related risk factors and manifestations in deep venous thrombosis

    by Bo Wu, Haoyuan Wang, Yujia Li, Jianming Sun, Lili Zhang, Haiyang Wang

    Objective: The incidence, risk factors, and clinical presentation of deep venous thrombosis (DVT) vary with age. This study aimed to evaluate the differences in clinical characteristics of DVT among patients of different ages. Methods: We retrospectively analyzed 938 patients with symptomatic lower extremity DVT admitted to our hospital between January 2020 and January 2024. Patients were categorized into youth (65 years) groups. Demographic data, comorbidities, risk factors, clinical presentations, and management approaches were collected and analyzed. Results: Most participants were middle-aged or elderly, with young patients constituting only 11.19% of the study population. The youth group had a slight female predominance, while the middle-aged and elderly group had a balanced gender distribution. The elderly group were more likely to have comorbidities such as diabetes and malignancies, though they had a lower prevalence of autoimmune diseases compared to younger patients. Congenital risk factors were relatively rare in the overall population, yet were present in 22.86% of young patients, a significantly higher proportion than in the middle-aged and elderly groups. Most patients with DVT were provoked, especially in the elderly group. The prevalence of concurrent congenital and acquired factors was 13.33% in the youth group, compared to only 4.97% in the middle-aged group and 2.88% in the elderly group. Proximal DVT was most frequent in middle-aged patients, while young patients were more likely to seek treatment in the acute phase and undergo surgical intervention. Anticoagulation noncompliance was noted in nearly 40% of elderly patients but only 6.67% of young patients. Conclusion: Risk factors and clinical characteristics of DVT vary significantly with age, particularly between young and elderly patients. Young patients were more inclined to seek prompt and effective treatment and demonstrated better adherence to anticoagulation therapy.


  • Open Access

    The Incidence, Risk Factors and Characteristics of Late (>2 Years) Recurrence of Deep Venous Thrombosis

    by Bo Wu, Jian Fu, Haiyang Wang, Haiyan Yan, Jianming Sun, Haoyuan Wang, Lili Zhang

    Objective: Recurrent deep venous thrombosis (RDVT) is a relatively frequent phenomenon; however, scarce literature is available on late RDVT (>2 years). This study aimed to investigate the incidence, associated risk factors, and characteristics of late RDVT. Methods: We conducted a retrospective analysis of patients diagnosed with symptomatic lower extremity deep venous thrombosis (DVT) between April 2017 and April 2022. The incidence and mortality rates of late RDVT, as well as the demographic data, risk factors, and characteristics, were assessed. Additionally, a comprehensive Cox regression analysis was performed to evaluate 14 potential risk factors. Results: Of the 638 patients with DVT, 89 (13.9%) experienced recurrence during a mean follow-up period of 30.10 ± 15.23 months. The RDVT group comprised 50 males and 39 females (the male-to-female ratio: 50/39), with a mean age of 64.08 ± 13.23 years (the age range: 26-88 years). Among them, early recurrence was observed in 57 (64%) patients, while late recurrence occurred in 32 (36%) after their initial symptomatic DVT episode. Late RDVT predominantly manifested in the contralateral lower extremity. Multivariate Cox regression analysis further identified proximal DVT, immobility, non-retrieved inferior vena cava filter (IVCF), and ≥50% stent extension into the inferior vena cava (IVC) as significant risk factors for late RDVT. Moreover, mortality among patients with late RDVT was low, with 2 (6.25%) dying during the follow-up period. Conclusions: Late RDVT is relatively infrequent within the RDVT cohort and primarily manifests in the contralateral lower extremity. Furthermore, patients with late RDVT have a low mortality rate. Proximal DVT, immobility, non-retrieved IVCF, and ≥50% stent extension into the IVC are strongly correlated with the development of late RDVT.


  • Percutaneous Mechanical Thrombectomy for Acute Symptomatic Iliofemoral Deep Venous Thrombosis Patients With Recent Aneurysmal Subarachnoid Hemorrhage

    by Menglin Nie, Jian Fu, Jianming Sun, Haiyang Wang

    Purpose: To investigate the efficacy, safety, and mid-term outcomes of percutaneous mechanical thrombectomy (PMT) for acute symptomatic iliofemoral deep venous thrombosis (DVT) patients with recent (within 4 weeks) aneurysmal subarachnoid hemorrhage (aSAH). Materials and methods: From January 2016 to February 2020, 11 acute symptomatic iliofemoral DVT patients with a recent history of aSAH were enrolled in this study. All patients had a history of aneurysm ligation or clipping previously, computed tomography (CT) scans revealed ventricular hemorrhage had been absorbed obviously and no residual aneurysm. The mean time of DVT onset after aSAH ictus was 19.2±4.5 days, and the mean Glasgow score was 6.8 ± 0.7 (range, 6–8). These patients underwent PMT with an 8 French Aspirex®S device (Straub Medical AG, Wangs, Switzerland), subsequent stenting was performed to relieve the underlying stenosis, followed by anticoagulation alone. The procedure-related complications were assessed after intervention. The follow-ups were conducted up to 1 year, the patency was evaluated via duplex ultrasonography, and the incidence of post-thrombotic syndrome (PTS) was evaluated using the Villalta scale. Results: Grade III (>90%) clearance was achieved in all 11 patients. Stenting was performed in 7 patients (63.6%). There were no cerebral rebleeding events or other severe complications except 1 puncture site bleeding during treatment. A total of 90.9% (10 of 11) of patients were alive at the 12 month follow-up, and 7 patients achieved a good functional outcome. At the 1 year follow-up, there was 1 patient (10%) with mild PTS. The ultrasound showed that the patency of the iliofemoral veins was 100%, and femoral valvular incompetence was observed in 1 patient. Conclusion: Percutaneous mechanical thrombectomy seems to be a feasible and safe treatment for acute iliofemoral DVT in selected patients with recent aSAH, and it shows promising results in restoring patency and reducing the risk of PTS.